Movatterモバイル変換

National Expert Group on Vaccine Administration for COVID-19

From Wikipedia, the free encyclopedia

Indian advisory committee to provide guidance related to COVID-19 vaccination

National Expert Group on Vaccine Administration for COVID-19
Abbreviation	NEGVAC
Legal status	Active
Location	India
Region served	India
Leader	V. K. Paul

National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) is an expert committee constituted by theMinistry of Health and Family Welfare (MoHFW), India to provide advice and guidance on all aspects ofCOVID-19 vaccination. The committee is also responsible for prioritisation of population groups in the country, deciding procurement and inventory management procedure, selection and delivery of vaccines etc.^[1]

Committee

[edit]

NEGVAC was constituted in mid-2020 and first met on 12 August 2020.^[2]^[3]^[4] is chaired by member (Health),NITI Aayog, and co-chaired by the secretary of MoHFW. The committee has representative secretaries from:^[1]

Vinod Kumar Paul^[3]
Department of Expenditure
Department of Biotechnology
Department of Health Research
Department of Pharmaceuticals
Ministry of Electronics and Information Technology
Members representing five state governments
Technical experts

Members include Samiran Panda, head of the Epidemiology and Communicable Diseases division in ICMR.^[5]

References

[edit]

^^a ^b"High Level Committee for Distribution and Administration of COVID-19 Vaccines".pib.gov.in. Retrieved19 May 2021.
^Das, Sohini (2020-08-17)."National Expert Group meets Covid-19 vaccine makers to discuss road ahead".Business Standard India. Retrieved19 May 2021.
^^a ^b"National Expert Group on Vaccine Administration for COVID-19 deliberates on strategy to ensure COVID-19 vaccines' availability and its delivery mechanism".pib.gov.in. Retrieved19 May 2021.
^"National Expert Group On Vaccine Administration Working On Management Of COVID-19 Vaccine Roll-Out: Government | News".NDTV-Dettol Banega Swasth Swachh India. 2020-12-09. Retrieved19 May 2021.
^Sharma, Neetu Chandra (2021-03-08)."'Govt to tailor jab strategy as per emerging evidence'".mint. Retrieved2021-06-03.

COVID-19 pandemic in India

Timeline
- 2020
  - January–May
  - June–December
- 2021
Statistics
- chart

Topics

Government response	Union government State governments Evacuations PM CARES Fund Lockdown Vaccination CoWIN Vaccine Maitri Tika Utsav WTO COVID-19 TRIPS waiver proposal

Incidents

Locations

States	Andhra Pradesh Arunachal Pradesh Assam Bihar Chhattisgarh Goa Gujarat Haryana Himachal Pradesh Jharkhand Karnataka Kerala timeline Madhya Pradesh Maharashtra Manipur Meghalaya Mizoram Nagaland Odisha Punjab Rajasthan Sikkim Tamil Nadu Telangana Tripura Uttar Pradesh Uttarakhand West Bengal
Union territories	Andaman and Nicobar Islands Chandigarh Dadra and Nagar Haveli and Daman and Diu Delhi Jammu and Kashmir Ladakh Lakshadweep Puducherry

Legal framework

Agencies and
institutes

Administration

Research
andtesting

Public	National Centre for Disease Control Integrated Disease Surveillance Programme Indian Council of Medical Research National Institute of Cholera and Enteric Diseases National Institute of Epidemiology National Institute of Virology Viral Research and Diagnostic Laboratories Central Drugs Standard Control Organisation Council of Scientific and Industrial Research Central Drug Research Institute Centre for Cellular and Molecular Biology Indian Institute of Chemical Biology Indian Institute of Chemical Technology Indian Institute of Integrative Medicine Institute of Microbial Technology Institute of Genomics and Integrative Biology National Chemical Laboratory National Institute of Biomedical Genomics National Accreditation Board for Testing and Calibration Laboratories
Private	Bharat Biotech Biocon Biological E. Limited Cadila Healthcare Cipla Dr. Reddy's Laboratories Glenmark Pharmaceuticals Hetero Drugs Lupin Limited Mylab Discovery Solutions Roche Diagnostics Serum Institute of India
Vaccines	BBV154 Covaxin (Bharat Biotech) Corbevax (Biological E. Limited) Covishield (Serum Institute of India) HGC019 (Gennova Biopharmaceuticals) ZyCoV-D (Cadila Healthcare)

Others

Officials

Union government	Narendra Modi(Prime Minister) Amit Shah(Union Home Minster) Harsh Vardhan,Mansukh Mandaviya(Union Health Minister) Rajiv Gauba(Cabinet Secretary) Ajay Kumar Bhalla(Union Home Secretary) Preeti Sudan,Rajesh Bhushan(Union Health Secretary)
State governments	Chief Ministers Lieutenant Governors and Administrators State Home Ministers State Health Ministers Chief Secretaries State Home Secretaries State Health Secretaries
Agency executives	Sujeet Kumar Singh(Director,NCDC) Balram Bhargava(Director General,ICMR) Shanta Dutta(Director,NICED) Manoj V. Murhekar(Director,NIE) Priya Abraham(Director,NIV) V. G. Somani(Drug Controller General) Shekhar C. Mande(Director,CSIR) Tapas Kumar Kundu(Director,CDRI) Rakesh Mishra(Director,CCMB) Samit Chattopadhyay(Director,IICB) S. Chandrasekhar(Director,IICT) Ram A. Vishwakarma(Director,IIIM) Sanjeev Khosla(Director,IIMT) Anurag Agrawal(Director,IGIB) Ashwini Kumar Nangia(Director,NCL) D. K. Aswal(Chairman,NABL) G. V. K. Reddy(Chairman,GVK EMRI) R. K. Jain(Secretary General,IRCS)

COVID-19 portal

Retrieved from "https://en.wikipedia.org/w/index.php?title=National_Expert_Group_on_Vaccine_Administration_for_COVID-19&oldid=1151204171"

Categories:

Hidden categories:

[8]ページ先頭